U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07286006) titled 'A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)' on Dec. 10.
Brief Summary: This is a long-term extension study that will rollover participants completing feeder studies IMVT-1402-2502 (NCT06727604) or IMVT-1402-2503 (NCT07018323) to evaluate the efficacy and safety of IMVT-1402 in adult participants with GD. Eligible participants will be assigned to 1 of 3 study groups (Groups A, B and C) based on their GD status at the completion of their respective feeder study.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Graves' Disease
Intervention:
DRUG: IMVT-1402
Dose 1 fo...